ANOAT THERAPEUTICS
Anoat Therapeutics develops an innovative, disease-modifying approach in Cystic Fibrosis.
ANOAT THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical Product Research Therapeutics
Founded:
2023-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Total Employee:
1+
Status:
Active
Total Funding:
2 M EUR
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
EpiVario
EpiVario develops novel compounds to treat memory-related psychiatric disorders at the source of the disease.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
VintaBio
VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.
Investors List
AdBio partners
AdBio partners investment in Seed Round - Anoat Therapeutics
More informations about "Anoat Therapeutics"
Anoat Therapeutics raises €2M in seed funding to develop novel ...
About Anoat Therapeutics Anoat Therapeutics is a preclinical-stage company focused on developing novel therapies to transform the lives of patients with rare diseases who have …See details»
€2m raised in seed funding to develop novel therapies …
Jun 19, 2023 Anoat will use the funds to conduct additional in vivo and in vitro pharmacology assessments and select a lead candidate. Anoat Therapeutics’ …See details»
Anoat Therapeutics - PitchBook
Anoat Therapeutics General Information Description. Developer of novel therapies intended to transform the lives of patients with rare diseases. The company specializes in bringing a …See details»
Anoat Therapeutics - VentureRadar
Anoat Therapeutics is a preclinical-stage company focused on developing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its …See details»
Anoat Therapeutics - Funding, Financials, Valuation & Investors
Jun 19, 2023 Anoat Therapeutics develops an innovative, disease-modifying approach in Cystic Fibrosis. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. …See details»
Anoat Therapeutics - Drug pipelines, Patents, Clinical trials - Synapse
Last update 01 Nov 2024. Anoat Therapeutics. Startups |See details»
Anoat Therapeutics raises €2M in seed funding to develop novel ...
Jun 19, 2023 Newly created biotech company first startup resulting from AdBio Partners and Inserm Transfert seed funding partnership. Anoat Therapeutics leveraging academic work …See details»
Paris-based Anoat Therapeutics raises €2 million Seed …
Jun 19, 2023 Founded in 2023, Anoat Therapeutics’ goal is to bring a transformative and mutation-agnostic treatment option to CF patients for whom existing therapies are not effective – i.e., patients not eligible or responsive to …See details»
Anoat raises funds to tackle cystic fibrosis - Labiotech.eu
Jun 20, 2023 Anoat Therapeutics, a French preclinical stage biotechnology company specialized in cystic fibrosis (CF), has raised €2 million ($2.17 million) in seed funding from AdBio partners. Anoat will use the funds to conduct …See details»
Paris-based Anoat Therapeutics raises €2 million Seed to develop …
Jun 19, 2023 Founded in 2023, Anoat Therapeutics’ goal is to bring a transformative and mutation-agnostic treatment option to CF patients for whom existing therapies are not effective …See details»
Anoat Therapeutics raises €2M in seed funding to develop novel ...
Jun 19, 2023 About Anoat Therapeutics. Anoat Therapeutics is a preclinical-stage company focused on developing novel therapies to transform the lives of patients with rare diseases …See details»
Anoat Therapeutics - Products, Competitors, Financials, Employees ...
Anoat takes aim at alternative chloride channel to treat cystic fibrosis. Aug 10, 2023. Aug. 10, 2023 With more than 70,000 people living with cystic fibrosis (CF) worldwide, according to the …See details»
Anoat Therapeutics receives cystic fibrosis funding boost
Jun 19, 2023 Anoat Therapeutics – a company focusing on therapies for cystic fibrosis (CF) – has announced it has raised €2m in seed funding through its AdBio partners. This critical …See details»
Anoat Therapeutics - Company Profile - Tracxn
Anoat Therapeutics - Developer of therapeutics to treat cystic fibrosis. Raised a total funding of $2.19M over 1 round from 1 investor. Founded by Vincent Bischoff and Alain Huriez in the …See details»
Anoat Therapeutics - Raised $2.19M Funding from 1 investor
Anoat Therapeutics has raised a total funding of $2.19M over 1 round from 1 investor. Investor includes AdBio partners. Their latest funding round was of $2.19M on Jun 19, 2023 .See details»
Seed Round - Anoat Therapeutics - 2023-06-19 - Crunchbase
Jun 19, 2023 Anoat Therapeutics raised $2184748 on 2023-06-19 in Seed Round. Start Free TrialSee details»
Anoat takes aim at alternative chloride channel to treat cystic ...
Aug 10, 2023 One startup hoping to address this is Anoat Therapeutics. With more than 70,000 people living with cystic fibrosis (CF) worldwide, according to the Cystic Fibrosis Foundation, …See details»
Anoat Therapeutics - Tech Stack, Apps, Patents & Trademarks
Organization. Anoat Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Patents and Trademarks by IPqwery. Edit …See details»